Specialist palliative care for patients with heart failure. Dr Katie Taylor Consultant in Palliative Medicine

Similar documents
Chronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update)

Palliative Care for Heart Failure. Service Development in West Hertfordshire

8. Pharmacological Management

Managing dying with chronic heart failure

National Horizon Scanning Centre. Irbesartan (Aprovel) for heart failure with preserved systolic function. August 2008

Heart Failure (HF) - Primary Care Flow Charts. Pre diagnosis Symptoms or signs suggestive of HF

Heart Failure (HF) - Primary Care Flow Charts. Symptoms or signs suggestive of HF. Pre diagnosis. Refer to the Heart Failure Clinic at VHK for

Guidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings

The Failing Heart in Primary Care

Heart Failure Vital steps for palliative care. Dr Karen J Hogg Glasgow Royal Infirmary

Specialist Palliative Care Audit and Guidelines Group (SPAGG)

CLINICAL PRACTICE GUIDELINE

Heart Failure Clinician Guide JANUARY 2016

Heart Failure Clinician Guide JANUARY 2018

1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare?

Summary/Key Points Introduction

Heart Failure Update John Coyle, M.D.

Palliative care for heart failure patients. Susan Addie

2016 Update to Heart Failure Clinical Practice Guidelines

Welcome (Kerry) What is Heart failure (Becca) Recognising Dying (Becca) Tea 20 mins Deactivation of ICDs (Lisa) Advanced care Planning (Jo) Any

The last days of life in hospital and at home

Management of chronic heart failure: pharmacology. Giuseppe M.C. Rosano, MD, PhD, FHFA

Polypharmacy: Guidance for Prescribing in Frail Adults

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Heart Failure. Jay Shavadia

Three triggers that suggest that patients could benefit from a hospice palliative care approach

The Role of Palliative Care in the Management of Advanced Heart Failure

Care of the dying in End Stage Kidney Disease (ESKD) - Conservative. Elizabeth Josland Renal Supportive Care CNC St George Hospital

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

2/3/2017. Objectives. Effective Heart Failure Management through Evidence Based Practice and Innovation

Oxford Kidney Unit A guide to conservative kidney management. Information for Healthcare Professionals

Breathlessness in advanced disease. February 2017

Incidental Findings; Management of patients presenting with high BP. Phil Swales

Optimizing CHF Therapy: The Role of Digoxin, Diuretics, and Aldosterone Antagonists

Heart Failure. Dr. William Vosik. January, 2012

Palliative and End of Life Care in End Stage Renal Disease

Supportive and Palliative care for patients with Pancreatic Cancer. Dr Holly Taylor September 2018

Specialist Palliative Care Referral for Patients

Specialist Palliative Care Service Referral Criteria and Guidance

Delivering personalised care to end of life patients. Jane Naismith Nurse Consultant in Palliative care St Joseph s Hospice London

STOPP START Toolkit Supporting Medication Review in the Older Person

A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

keyword: diuretics Drug monitoring Monitoring diuretics in primary care 2 March 2009 best tests

Appropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Diastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012

Community and Mental Health Services. Palliative Care. Criteria and

Heart Failure: Combination Treatment Strategies

Heart Failure Management Policy and Procedure Phase 1

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Preventing harmful treatment

CareFirst Hospice. Health care for the end of life. CareFirst

Life is pleasant. Death is peaceful. It s the transition that s troublesome. Isaac Asimov ( )

New Advances in the Diagnosis and Management of Acute and Chronic Heart Failure

Understanding Parkinson s for health and social care staff. The phases of Parkinson s

I have no financial disclosures.

Enhancing the Quality of Heart Failure Care

TRAJECTORY OF ILLNESS IN END OF LIFE CARE

NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT

Cardiology. Presented by: Dr Paul Bethell GP Lead for Planned Care

Cancer associated thrombosis palliative care and the end of life. Tracy Anderson May 2017

Enhancing the Quality of Heart Failure Care

STANDARD treatment algorithm mmHg

CHF for Clinician. AtHomeCare.com

NICE Chronic Heart Failure Guidelines in Adults 2018

OPTIMAL MANAGEMENT OF ELDERLY HEART FAILURE PATIENT. Dr Eilidh Hill ST7 Geriatric Medicine Glasgow Royal Infirmary

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

Coronary Heart Disease. Iqbal Malik

Cardiology. Heart Failure. Information

ICD deactivation Patient Journey

What s new in heart failure management? Yonsei Cardiovascular Center Yonsei University College of Medicine

Index. Note: Page numbers of article titles are in boldface type.

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Cover images courtesy of jk1991 at FreeDigitalPhotos.net Infographics courtesy of SIMPATHY consortium

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

DEPRESCRIBING IN THE ELDERLY

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?

HEART FAILURE: PHARMACOTHERAPY UPDATE

Heart Failure. Dr. Alia Shatanawi

Heart Failure from a GP perspective

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

ACUTE HEART FAILURE. Julie Gorchynski MD, MSc, FACEP, FAAEM. Department of Emergency Medicine Emergency Residency Program UTHSC, San Antonio TCEP 2014

Prescribing appropriately. May 2016

Adherence to health behaviour advice in heart failure

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

PACES Station 2: HISTORY TAKING

Objectives. Heart failure and Hypertension. Definition & epidemiology of heart failure HEART FAILURE 3/12/2016. Kirsten Bibbins-Domingo, PhD, MD, MAS

End of Life Care in Dementia. Dr Rosie Lockwood Consultant Geriatrician Sheffield Teaching Hospitals

New NICE Heart Failure Guidelines What do they mean for primary and secondary care, and patients?

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology

Renal Supportive Care. Renal Supportive Care Symposium 2013 Elizabeth Josland CNC

I have no disclosures. Disclosures

Diagnosis and management of chronic heart failure

Intelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork

ESCALATING PATIENT & CARER NEEDS TOWARDS END OF LIFE; OVERVIEW OF END OF LIFE CARE IN THE COMMUNITY Renal Supportive Care Nursing Elizabeth Josland

Akash Ghai MD, FACC February 27, No Disclosures

The Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician

Transcription:

Specialist palliative care for patients with heart failure Dr Katie Taylor Consultant in Palliative Medicine

Objectives Identify which patients to refer to hospice Review symptom management Think about rationalising medications Be aware of services which the hospice could provide

Questions to consider What are the barriers to providing good end of life care for patients with heart failure? What works well? What is more challenging? Are there specific patient examples that you can share?

Some heart failure statistics 500,000 people in UK 76y - average age at diagnosis 30-40% die within 1 year Costs NHS 378.6 million/year 2% of all NHS inpatient bed days 5% of all emergency admissions Cardiovascular disease statistics 2014 BHF

More statistics Prevalence of heart failure rising Ageing population Improved survival with IHD Improved heart failure treatment 6 month mortality rate falling: 26% 1995 to 14% 2005 Hospital admissions predicted to rise by 50% over next 25 years

NYHA classification

Morbidity Significant symptom burden Patients have poor understanding of illness progression Less likely to plan for death & dying 83-95% die in acute or elderly care hospital bed 1% die in hospice

When to refer to hospice The typical disease trajectories identified in patients with different diseases.

Integrated palliative/cardiology services Which deterioration is the terminal one? Change of emphasis from active to palliative management difficult Indicators of poor prognosis provide a trigger for conversations about future plans what would you want to do if things get worse Heart failure MDT

Indicators of Poor Prognosis Previous admissions with worsening heart failure No identifiable reversible precipitant Receiving optimum tolerated conventional drugs Worsening renal function and low sodium Failure to respond within 2-3 days to appropriate change in diuretic or vasodilator drugs Sustained hypotension Up to 50% patients with heart failure die suddenly

Specific clinical indicators for heart failure: CHF NYHA Stage 3 or 4 Patient thought to be in last year of life Repeated hospital admissions with heart failure symptoms Physical or psychological symptoms despite optimal tolerated therapy

Roles of specialist palliative care

Symptoms Anderson et al (2001) Pall Med 15(4): 279-86

SOB Non-pharmacological Relaxation/distraction Breathing retraining Lifestyle changes Hand-held fan Complementary tx Exercise group Drugs Oramorph 2.5mg 4hrly Lorazepam 0.5mg prn GTN spray

Fatigue Exclude reversible causes Hb, TFTs, U&E, calcium, magnesium Review medication Beta blockers, ACE Screen for anxiety/depression Pace activity Graded exercise Dietary advice

Polypharmacy Chronic use of >4 medications 36% patients over 75 take >4 drugs 50% drugs are not taken as prescribed Drug interactions Adverse reactions Pill burden

ADRs

Rationalising medications Which medications are providing immediate symptom benefit? Which medications might produce rebound symptoms/rapid deterioration if stopped?

Consider 1 st Consider 2 nd Consider 3 rd Discontinue drugs with only long term benefit (mortality) Statins Digoxin (in sinus rhythm) Weigh up advantages/disadvantages of continuing drugs with medium term benefit (morbidity/mortality) ACE/ARB Beta blocker Spironolactone Drugs for co-morbidities Hypoglycaemics Antihypertensives Thyroxine Warfarin Continue drugs for short term benefit (morbidity) Loop & thiazide diuretics Digoxin/beta-blockers (in AF) Anti anginals

Subcutaneous furosemide Patient selection Advanced CHF Wish to avoid hospital Need parenteral diuretics Indications Symptom management End of life Unresponsive to high dose oral diuretics PPC home/hospice Poor venous access

Paracentesis Patients with right heart failure Ascites persists despite aggressive diuretic tx Symptomatic 4-6 litre slow paracentesis Over few days

Input from palliative care Hospital Hospice day service Hospice in the home Hospice inpatient unit Counselling Carer support